PI(3,4)P2 PolyPIPosomes
|
|
Catalog No.:
Y-P034
Description:
PolyPIPosomes are polymerized liposomes that show markedly increased stability (up to 6 months) vs. conventional liposomes. A biotin tag is incorporated for easy detection of PIPn-binding proteins with streptavidin reagents.
- Uniform size (~200 nm)
- Ready-to-use suspensions, no liposome preparation
PolyPIPosomes have demonstrated utility in a number of assay formats:- -Protein pull-down
- -Surface Plasmon Resonance
- -Liposome overlay assay
|
|
|
PI(3,4)P2 PolyPIPosomes are provided as a 1mM total lipid solution containing 5% PI(3,4)P2. Each order of 250 μL or 1 mL of PolyPIPosomes includes 100 μL of Control PolyPIPosomes (Y-0000).
Featured in Publications:1) Ferguson, C. G., R. D. James, et al. (2005). "Phosphoinositide-Containing Polymerized Liposomes: Stable Membrane-Mimetic Vesicles for Protein-Lipid Binding Analysis." Bioconjug Chem 16(6): 1475-1483.
2) Elkin, S. K., D. Ivanov, et al. (2005). "A PHD finger motif in the C-terminus of RAG2 modulates recombination activity." J Biol Chem 280(31): 28701-10.
3) Mustafa, A. K., D. B. van Rossum, et al. (2009). "Glutamatergic regulation of serine racemase via reversal of PIP2 inhibition." Proc Natl Acad Sci U S A 106(8): 2921-6.
4) Zemskov, E. A., I. Mikhailenko, et al. (2011). "Unconventional secretion of tissue transglutaminase involves phospholipid-dependent delivery into recycling endosomes." PLoS One 6(4): e19414.
5) Tiwari, S., H. P. Choi, et al. (2009). "Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P(2) and PtdIns(3,4,5)P(3) promotes immunity to mycobacteria." Nat Immunol 10(8): 907-17.
Being bio-reactive blog: "Lipid-Ligand interaction tools: lipids are not scary intermediates anymore"
|
| Options/Sizes |
Pricing |
| Y-P034-100ul |
$ 217.00 |
| Y-P034-250ul |
$ 517.00 |
| Y-P034-1ml |
$ 1,935.00 |
|
Additional Information:
Tech Data Sheet - TDS_Y-P00xx_ Rev8
|
|
Back to the webstore startpage
Back to the product overview
Your Shopping Cart
Terms of Service
assay and reagents for drug discovery in lipid signaling pathways
